GAtherton, Author at Aspergillosis Patients & Carers Support

🧵 Why Am I Getting More “Plugs” This July?

A message for aspergillosis patients

July is often a time when people with aspergillosis feel a bit better — but sometimes, things don’t go quite to plan. If you’ve suddenly started getting more mucus “plugs” or are struggling to clear your chest, here are some possible reasons:

🔍 Common Reasons for More Mucus or Plugs in Summer

Possible Cause	Why it might affect you now
Fungal spores are high	July and August bring very high outdoor levels of Aspergillus, Cladosporium, and other moulds – especially on dry, windy days or after cutting grass. These can trigger inflammation and more mucus.
Pollen season continues	Even though tree pollen has gone, grass, weed, and cereal pollen are still in the air. These can worsen symptoms for people with ABPA or asthma.
Humidity or storms	Sudden weather changes, humid air, or storms can make breathing more difficult and mucus harder to shift. Some people call this "thunderstorm asthma."
Air pollution (ozone)	Sunny weather increases ozone and air pollution – both can irritate your airways.
Low-level infection or flare-up	If your mucus is thicker, darker, or smells different, it might be a sign of a fungal or bacterial flare-up, even without a high temperature.
Hydration or medication changes	Less water, skipping nebulisers, or changes in routine can make mucus stickier.
Blocked sinuses	Post-nasal drip from fungal sinusitis can make it feel like mucus is always sitting in your throat or upper chest.

✅ What You Can Do

Drink more fluids, especially warm water or squash
Use saline in your nebuliser to loosen thick mucus
Do your chest clearance exercises more often – flutter device, ACBT, or huffing
Don’t skip antifungals, inhalers, or mucolytics like carbocisteine
Consider a nasal rinse if your sinuses feel blocked
Keep windows closed on high spore or high pollen days
Speak to your team if things don’t settle – you may need a review or antibiotics

⚠️ When to Get Checked

You're coughing up yellow, green or brown mucus
Mucus smells bad or has blood in it
You feel more breathless or more tired
You’ve needed to increase your nebuliser use

💬 You're Not Alone

Many patients with aspergillosis get more mucus at this time of year — even when the sun’s out! Don’t assume it’s “just the weather.” Sometimes it’s a sign that your lungs or sinuses are reacting to invisible spores in the air.

by GAtherton

Other forms of aspergillosis: Aspergillus Empyema, A Rare and Serious Complication of Aspergillosis

What Is Aspergillus Empyema?

Aspergillus empyema is a very rare but serious fungal infection where Aspergillus invades the pleural space — the thin cavity between the lungs and the chest wall. Normally, this space contains a small amount of lubricating fluid. In empyema, it fills with infected pus, often due to rupture from a lung cavity or complication following severe illness or surgery.

In this form of aspergillosis, the infection goes beyond the lungs into the lining around the lungs (pleura), and is typically seen in people with severe underlying lung disease or who are very immunocompromised.

How Rare Is It?

Type of Aspergillosis	Estimated Cases per 100,000 People	How Common?	Who Is Most at Risk?
ABPA (Allergic Bronchopulmonary Aspergillosis)	~40–60	Moderately common	People with asthma or cystic fibrosis
CPA (Chronic Pulmonary Aspergillosis)	~3–4	Uncommon	People with underlying lung disease (e.g. TB, COPD)
Aspergilloma (fungus ball)	~0.5–1	Rare	People with lung cavities (often overlaps with CPA)
Aspergillus Empyema	< 0.1	Very rare	Severely immunocompromised or critically ill ICU patients

Most people living with ABPA or CPA will never develop Aspergillus empyema.

Who Is at Risk?

Risk of empyema increases in people who have:

Severely weakened immune systems (e.g. high-dose corticosteroids, cancer treatment, transplant)
Lung surgery, trauma, or chest drain procedures
A ruptured aspergilloma (fungus ball)
Existing lung cavities (from TB, sarcoidosis, or CPA)
Severe COVID-19 or ARDS (acute respiratory distress syndrome) with damaged lung tissue

Even among high-risk patients, Aspergillus empyema remains rare.

Symptoms

Fever that does not improve with antibiotics
Chest pain or tightness
Breathlessness
Cough (may be foul-smelling)
Persistent fluid seen on chest X-ray or CT scan

Diagnosis

Doctors may use:

CT scans or chest X-rays to detect fluid or cavities
Pleural fluid sampling (for fungal culture, galactomannan, PCR)
Tissue biopsy in difficult or unclear cases

Treatment Options

1. Drain the Infected Fluid

Chest drain (tube)
Surgical drainage in complex cases

2. Antifungal Therapy

Usually voriconazole (oral or IV)
Treatment may last months, depending on response

3. Surgery

May include decortication (removing infected pleura)
Repair of fistulas or ruptured cavities
Muscle or fat flaps to prevent recurrence and close space

4. Other Measures (used selectively)

Intrapleural antifungal instillation (amphotericin)
Endobronchial valves or spigots to manage air leaks

Outcomes and Prognosis

Historically high mortality (30–75%), mostly due to delayed diagnosis or underlying illness
Outcomes improving with specialist antifungal and surgical treatment
Early intervention saves lives

Summary for Patients

Aspergillus empyema is very rare, and affects only a tiny number of people with aspergillosis — usually those who are very unwell, immunocompromised, or post-surgery.
It is treatable with antifungals, drainage, and sometimes surgery.
Most people with ABPA or CPA will never experience this complication.
Stay aware of symptoms, and ensure regular check-ups if you have known lung cavities or risk factors.

by GAtherton

Other forms of aspergillosis: 🛡️ Tracheobronchial Aspergillosis (TBA), A Rare Airway Form of Aspergillus Infection

🌿 What is Tracheobronchial Aspergillosis?

Tracheobronchial aspergillosis (TBA) is a rare type of aspergillosis that affects the large airways (the trachea and bronchi), rather than the deeper parts of the lungs. It happens when Aspergillus, a common environmental mould, starts to grow in the airways, either sitting in mucus or, in severe cases, invading the airway wall itself.

❗How Rare Is It?

TBA is uncommon — even among people who already have aspergillosis.
It is mostly seen in:

Very unwell hospitalised patients
People with severe immune suppression
Patients in intensive care units (ICU)

🧠 If you have ABPA, CPA, asthma, or chronic sinus issues, your risk of developing TBA is usually very low, unless your immune system becomes severely weakened.

🔍 What Causes It?

The Aspergillus fungus is found everywhere — but in some people with weak defences, it can take hold in the airways. Depending on the type and severity, this can cause:

Thick fungal mucus or plugs in the airways
Persistent coughing or wheezing
Breathlessness
In serious cases, damage to the airway lining or even bleeding

🚨 Who Is Most at Risk?

People most at risk of invasive or serious TBA include those who are:

High-Risk Group	Why They're at Risk
ICU patients on ventilators	Damaged airways + suppressed local immunity
Patients with severe viral pneumonias (e.g. COVID-19, influenza)	Airways inflamed and vulnerable
Stem cell or organ transplant recipients	Profound immune suppression
Cancer patients undergoing chemotherapy	Low white blood cells (neutropenia)
People on high-dose steroids or immunosuppressants	Weakens the body's response to fungal growth
People with COPD or bronchiectasis in critical care	Pre-damaged airways and infection risk

🧬 What About People with CPA, ABPA, or Asthma?

Many people living with:

Chronic Pulmonary Aspergillosis (CPA)
Allergic Bronchopulmonary Aspergillosis (ABPA)
Asthma with fungal sensitisation (SAFS)

…may worry that Aspergillus in their lungs or sinuses could spread to their airways.

🟢 Good news: TBA is not common in these groups unless:

You become severely immunocompromised (e.g. after a transplant or due to high-dose steroids)
You are admitted to ICU or receive strong immunosuppressive therapy

If you are on replacement doses of steroids (e.g. for adrenal insufficiency) or biologics for asthma, your risk is generally low, especially if you are also on antifungal treatment when needed.

🧪 How Is TBA Diagnosed?

Doctors may consider TBA if someone at risk develops:

New or worsening cough
Mucus that won’t clear
Breathing difficulties
Signs of bleeding in the airways

Diagnosis may involve:

Bronchoscopy (looking into the lungs with a camera)
Bronchoalveolar lavage (BAL) to test for Aspergillus DNA or galactomannan
CT scans of the chest

💊 How Is TBA Treated?

Treatment depends on whether the infection is simply growing in mucus or is invading tissue:

Type of TBA	Treatment
Fungal growth in mucus only	Bronchoscopic removal of plugs ± antifungals if immunocompromised
Inflammation of airway lining	Oral or inhaled antifungals, possibly systemic therapy if symptoms persist
Tissue-invasive TBA	Urgent treatment with voriconazole or isavuconazole, often for 6–12 weeks; sometimes with amphotericin or an echinocandin

✅ Summary for Aspergillosis Patients

Question	Answer
Is TBA common?	❌ No — it is rare
Who usually gets it?	ICU patients, transplant recipients, cancer patients, or those with severe immune suppression
Can people with CPA or ABPA get TBA?	🟠 Possibly — but only if their immunity becomes severely weakened
Are replacement steroids or asthma biologics risky?	🟢 Not usually — especially if antifungal cover is used when needed
Is it treatable?	✅ Yes — if caught early and treated appropriately with antifungals

🧠 Final Advice

If you have any form of aspergillosis, it's important to work closely with your clinical team. Most people will never develop TBA. But if you are on strong immune-suppressing treatment or become very unwell in hospital, make sure your team is aware of your history. With careful monitoring and the right treatment, outcomes can be good.

by GAtherton

🛡️ Understanding Your Risk: Aspergillosis, Steroids, and the Immune System

If you’ve been diagnosed with an Aspergillus-related condition, such as chronic pulmonary aspergillosis (CPA), ABPA, or a fungal ball (aspergilloma), you might wonder:
“Am I immunocompromised? And do steroids or biologics put me at more risk?”

The answers depend on your underlying health, medications, and how your body responds to Aspergillus.

🌍 Aspergillus is Common — But Not Harmless

Aspergillus is a type of mould found everywhere — in soil, air, and dust. Most people breathe it in daily without problems. But in some people, it can:

Trigger an allergic reaction (ABPA or fungal sinusitis)
Cause infection in damaged lungs (CPA or aspergilloma)
Spread aggressively in those with very weak immune systems (invasive aspergillosis)

Understanding your level of immune defence helps explain your risk and how your treatment should be managed.

🧬 Levels of Immunocompromise: What They Mean

Immunosuppression isn't black-and-white — it's a spectrum. Here's how it applies to people with or at risk of aspergillosis:

🔴 High-Level Immunosuppression (High Risk)

Recent chemotherapy or bone marrow transplant
Stem cell or organ transplant
Severe neutropenia (very low white blood cell count)
High-dose steroids (e.g. ≥20 mg prednisolone daily for weeks)
Uncontrolled HIV/AIDS
Intensive care or mechanical ventilation

🧠 These people are at risk of serious, fast-spreading infections — including invasive aspergillosis (IA), which is rare but life-threatening.

🟠 Moderate Immunosuppression (Common in Aspergillosis Patients)

Long-term low-to-moderate steroids (e.g. <10–15 mg prednisolone)
Biologics for asthma (e.g. omalizumab, benralizumab)
Chronic lung disease (COPD, bronchiectasis, asthma)
Diabetes, malnutrition, or genetic immune traits
Previous TB, sarcoidosis, or other lung damage

🧠 This group is at greater risk of chronic forms of aspergillosis — especially CPA, ABPA, and aspergillus bronchitis.

🟢 Low or No Immunosuppression (Low Risk)

People with well-controlled asthma or sinusitis
Those on occasional short courses of steroids
No major lung or immune conditions

🧠 This group is unlikely to develop aspergillosis.

💊 What if You Already Have Aspergillosis?

If you’ve been diagnosed with CPA, ABPA, aspergilloma, or sinus disease caused by Aspergillus, some treatments may still increase your vulnerability if not carefully managed.

❗ Steroids (e.g. Prednisolone)

Help control inflammation (especially in ABPA)
But also suppress immunity, making it easier for Aspergillus to grow
Can worsen CPA or increase risk of bleeding in aspergilloma
Risk rises with higher doses and longer courses

🟠 If steroids are needed, they should usually be combined with antifungal medication (like itraconazole or voriconazole) to keep fungal growth in check.

❗ Biologics for Asthma (e.g. Omalizumab, Mepolizumab)

Target allergic inflammation without broadly suppressing the immune system
Don’t usually increase the risk of invasive fungal infections
May slightly alter how your immune system responds to Aspergillus

🟠 Biologics can be helpful in ABPA and severe asthma, but regular monitoring is still important.

🔍 Summary Table: Common Risk Factors and What They Mean

Factor	What It Does	What to Watch For
Long-term steroids	Suppress immune cells, reduce inflammation	Use with antifungals; monitor closely
Biologics for asthma	Modulate immune pathways (e.g. IgE, IL-5)	Safe in most; watch for subtle effects
TB, sarcoid, or other lung scarring	Leaves cavities that allow fungal growth	Regular scans and blood tests
Diabetes or malnutrition	Affects immune function and tissue repair	Keep well-managed
Low white blood cells (neutropenia)	Limits ability to fight fungal infection	Urgent action needed if fever or unwell
Lung diseases (COPD, asthma, bronchiectasis)	Reduce local lung defences	Increases risk of CPA, ABPA, or colonisation

✅ What Can You Do to Stay Safe?

Take antifungals as prescribed, especially if you're on steroids or biologics
Avoid unnecessary long-term steroid use — use the lowest dose for the shortest time
Report new or worsening symptoms early — especially breathlessness, coughing blood, fatigue, or sinus pain
Have regular follow-ups with your respiratory or infectious diseases team
Don’t stop any medication suddenly — especially steroids — without medical advice

💬 Final Reassurance

Having aspergillosis doesn’t mean you’re severely immunocompromised — but some treatments can increase your risk if not managed carefully. With the right balance of antifungals, asthma treatments, and medical support, many people live well with ABPA, CPA, and related conditions.

by GAtherton

Other forms of Aspergillosis

The majority of patients with aspergillosis will have forms that affect their lungs, as of course, that is where most exposure to Aspergillus occurs when we inhale the spores. There are, however, many more areas of our bodies that can be infected with Aspergillus. The sites of infection are much more difficult for spores to reach, so these forms of aspergillosis are much rarer compared with pulmonary forms, but they do occasionally happen, and as this is a website concerned with all forms of aspergillosis, we will try to summarise each form in this series of articles.

If you have been diagnosed with one of these rarer forms of aspergillosis you are welcome to join our support groups on Facebook, but be sure to explain which form you have, in any questions that you may ask, to avoid confusion. Different forms of aspergillosis can be treated in very different ways so be sure that the information you read is relevant to your aspergillosis.

There has long been a listing of other forms of aspergillosis in the treatment section of the Aspergillus & Aspergillosis website. These articles are intended for medical specialists so we will attempt to interpret them here for patients & non-specialists and also provide updated information where appropriate.

by GAtherton

Other forms of Aspergillosis: 🔬 Acute Invasive Aspergillus Sinusitis (AIAFS)

⚠️ A rare and severe fungal sinus infection — seen almost exclusively in people with severely weakened immune systems

🧾 What is it?

Acute Invasive Aspergillus Sinusitis (AIAFS) is a rapidly progressing fungal infection of the sinuses, caused by Aspergillus species (typically A. fumigatus). It leads to tissue invasion, destruction, and potentially fatal complications if not treated urgently.

🛡️ Who is at Risk of Acute Invasive Aspergillus Sinusitis?

Acute Invasive Aspergillus Sinusitis (AIAFS) is very rare, and affects people who are significantly immunocompromised — meaning their immune systems are unable to control even common environmental fungi.
However, “immunocompromised” is not always black-and-white. There are different degrees of vulnerability, and it's important to understand who is at greatest risk.

🔴 High-risk (severe immunosuppression)

These individuals are at the greatest risk for AIAFS:

Profound neutropenia (especially <500 neutrophils/μL for >10 days)
Acute leukaemia or stem cell transplantation
Solid organ transplant recipients on strong immunosuppressive regimens
High-dose corticosteroids (e.g. ≥20 mg prednisolone/day for ≥2 weeks)
Uncontrolled HIV/AIDS with low CD4 counts (<200)
Diabetic ketoacidosis or severe metabolic acidosis

🟠 Intermediate-risk (chronic or moderate immunosuppression)

Patients in this category may not be at risk of AIAFS, but may still be more vulnerable to chronic or allergic forms of aspergillosis or other infections:

Long-term oral corticosteroids at lower doses (e.g. <10 mg/day)
Biologic therapies for asthma (e.g. anti-IL-5, anti-IgE), which may subtly modulate immunity
Genetic susceptibility (e.g. subtle immune pathway deficiencies identified in CPA or ABPA)
COPD, bronchiectasis or severe asthma with impaired local defence
Malnutrition or poorly controlled diabetes

These patients are not typically at risk of invasive sinus aspergillosis, but may experience worsening of fungal conditions or atypical presentations of infection.

🟢 Low-risk (normal immune function)

People with normal immune function — even those with:

Allergic rhinitis
Chronic rhinosinusitis
Mild asthma or occasional infections

…are not at risk of developing AIAFS. Everyday exposure to Aspergillus spores is harmless to most people.

💬 Key Clarification:

Having aspergillosis does not automatically mean you are at risk of invasive sinus infection.
Many patients with CPA, ABPA, or SAFS are immunologically “fragile,” but not severely immunocompromised.
AIAFS typically only occurs in people with a combination of immune suppression and a very specific set of risks — especially when white blood cell function is severely impaired.

📋 Symptoms and Signs (typically <4 weeks onset)

Fever that does not respond to antibiotics
Facial pain or pressure, often severe and one-sided
Nasal congestion, discharge (often bloody or blackish)
Dark scabs (eschar) on the nasal mucosa or palate
Eye swelling, visual changes, or cranial nerve symptoms (if spread to the orbit or brain)
Altered mental state, seizures (in advanced cases)

🧪 Diagnosis

AIAFS is diagnosed based on:

Clinical suspicion in a high-risk patient
Endoscopic examination with biopsy and histology (showing hyphal invasion of tissue)
CT/MRI imaging to assess spread (bone, orbit, brain)
Culture and molecular testing of sinus material
Aspergillus PCR or galactomannan testing may help, but are not definitive alone

💊 Treatment Approach

Treatment must begin urgently, ideally within hours of suspicion.

1. Systemic antifungal therapy

First-line: Voriconazole or Isavuconazole
Alternatives: Liposomal Amphotericin B
Combination therapy may be considered in some cases
Therapeutic drug monitoring is essential (especially for voriconazole)

2. Surgical debridement

Prompt and aggressive endoscopic surgery is critical
Repeat procedures may be needed to remove necrotic tissue

3. Immunological support

Reversal of neutropenia if possible (e.g. G-CSF)
Reduction or withdrawal of immunosuppressive drugs
Management of underlying condition (e.g. glycaemic control in diabetes)

📈 Prognosis

Mortality is high (>50%) if not recognised and treated early
With rapid antifungal therapy and surgery, survival improves significantly
Regular monitoring, follow-up imaging, and immune recovery are crucial to long-term outcomes

🧠 Key Points to Remember

✅ This is a medical emergency, but
✅ It is extremely rare, and
✅ Almost exclusively affects those with profound immune suppression
✅ Not a risk to the general public or people with typical sinus infections

📣 Summary for Patient Awareness

Acute Invasive Aspergillus Sinusitis is very rare.
It is a fast-moving sinus infection caused by a fungus called Aspergillus, but it only happens in people with very weak immune systems, like those having chemotherapy or organ transplants.
It needs urgent treatment with antifungal medicine and sometimes surgery.
If your immune system is normal, this infection is not a risk to you.

by GAtherton

🩺 Why an Accurate Diagnosis Matters in Aspergillosis

If you've been told you have aspergillosis — or one of its forms like ABPA or CPA — you may wonder:
"Why does the exact diagnosis matter?"

Isn’t treatment just treatment?

Actually, no. In aspergillosis, getting the right diagnosis makes a huge difference to your care, safety, and long-term health.

This article explains why an accurate diagnosis is essential – not just for treatment, but also for recovery, monitoring, access to specialist care, and living well with the condition.

🔍 What Are ABPA and CPA?

Both ABPA and CPA are caused by the Aspergillus mould, but they affect the body in very different ways:

Condition	Description
ABPA (Allergic Bronchopulmonary Aspergillosis)	An allergic reaction to Aspergillus in the lungs. Most common in people with asthma or cystic fibrosis.
CPA (Chronic Pulmonary Aspergillosis)	A chronic lung infection with Aspergillus. Often seen in people with damaged lungs (e.g. past TB, COPD, bronchiectasis).

Because the symptoms can overlap (like coughing, mucus, or fatigue), it's not always easy to tell them apart — but the treatments are completely different.

🎯 Why Accurate Diagnosis is So Important

1. ✅ Get the Right Treatment

Different types of aspergillosis need very different medicines.

Diagnosis	Main Treatment	Notes
ABPA	Steroids (e.g. prednisolone), sometimes antifungals (like itraconazole)	Helps control inflammation and allergy
CPA	Long-term antifungals (e.g. itraconazole, voriconazole, posaconazole)	Steroids may make CPA worse

A wrong diagnosis can lead to the wrong treatment — and that can delay recovery or cause harm.

2. 📆 Plan Your Long-Term Care

Each condition has its own journey:

ABPA tends to flare up and settle down, often alongside asthma.
CPA is usually chronic and progressive, slowly damaging the lungs if untreated.

Knowing your diagnosis helps your doctors decide:

How often to scan your lungs (CT or X-rays)
What blood tests to monitor (e.g. IgE for ABPA, IgG for CPA)
How long to continue medication
What symptoms need urgent review

3. ⚠️ Avoid Side Effects and Harm

If you're given steroids for the wrong condition (e.g. CPA), they can:

Weaken your immune system
Let the fungal infection get worse
Increase the risk of diabetes, weight gain, or bone thinning

And if you’re given antifungals for ABPA without treating the allergy side, you might still keep having flare-ups.

A correct diagnosis helps your team weigh up risks and benefits — and adjust safely.

4. 🏥 Access the Right Specialist Services

In the UK, some treatments are only available for specific diagnoses:

Biologic drugs like omalizumab or mepolizumab are only available for severe ABPA under strict NHS criteria.
Long-term antifungal treatment for CPA is provided by highly specialised services, such as the National Aspergillosis Centre in Manchester.

Without the right diagnosis on record, access to these treatments may be delayed or blocked.

5. 🧭 Understand What to Expect

An accurate diagnosis helps you understand:

What symptoms are normal, and what should be reported
Whether your condition is likely to get better, stay the same, or slowly worsen
What lifestyle changes, home monitoring, or support groups might help

It also allows your care team to link you to others with similar conditions — for advice, reassurance, and shared experiences.

🧪 What Tests Help Make the Diagnosis?

Your specialist may request:

Blood tests (e.g. IgE, IgG antibodies to Aspergillus)
CT scans to look at the shape of your lungs
Sputum or bronchoscopy samples to grow or detect the fungus
Breathing tests (lung function) to assess airflow and trapping

These help build a full picture — no one test is enough on its own.

💬 In Summary

“Aspergillosis” is an umbrella term — but the exact type you have really matters.

Getting the correct diagnosis helps ensure:

🧬 You get the most effective treatment
📊 You avoid unnecessary harm
📆 You have the right follow-up plan
🧠 You understand your condition better
🩺 You can access the right NHS services

If you're not sure which type of aspergillosis you have — or you feel your diagnosis hasn’t been reviewed in a while — speak to your GP or respiratory team.

by GAtherton

🫁 Understanding Bronchiectasis, COPD, and Aspergillosis: What Patients Need to Know

Living with a lung condition can be confusing — especially when the symptoms of bronchiectasis, COPD, and aspergillosis are so similar. This guide explains the differences, how they are diagnosed, and why many people are wrongly diagnosed (or underdiagnosed) at first.

🌬️ What Are These Conditions?

Bronchiectasis

A condition where the airways become damaged, widened, and scarred, often from past infections, immune problems, or conditions like ABPA or CPA. This makes it hard to clear mucus, leading to regular infections.

COPD (Chronic Obstructive Pulmonary Disease)

A group of conditions — including emphysema and chronic bronchitis — that cause narrowed airways and damaged air sacs. Most often caused by smoking or long-term exposure to fumes or dust.

Aspergillosis

An infection or allergic reaction caused by the fungus Aspergillus. Types include:

ABPA (allergic bronchopulmonary aspergillosis) — mostly in asthma or bronchiectasis
CPA (chronic pulmonary aspergillosis) — causes lung cavities and fungal balls
Aspergillus bronchitis — low-grade infection in people with bronchiectasis

🔄 Shared Symptoms

All three can cause:

Symptom	Bronchiectasis	COPD	Aspergillosis
Chronic cough	✅	✅	✅
Sputum (phlegm)	✅ (often a lot)	✅ (varies)	✅ (sticky, sometimes brown)
Breathlessness	✅	✅	✅
Recurrent infections	✅	✅	✅
Fatigue	✅	✅	✅
Wheezing	Sometimes	✅	✅ in ABPA
Coughing blood (haemoptysis)	✅	⚠️	✅ (especially in CPA)

Because the symptoms are so similar, many people with aspergillosis are first told they have COPD or bronchiectasis until further tests are done.

🖥️ How Are They Diagnosed?

🧪 Tests Used

Test	Helps Diagnose
Spirometry (lung function)	COPD or asthma (airflow obstruction)
High-resolution CT scan	Bronchiectasis, CPA, emphysema
Aspergillus IgG & IgE blood tests	CPA (IgG), ABPA (IgE)
Sputum culture or PCR	Finds Aspergillus or bacterial infections
Eosinophil count	High in ABPA
Chest X-ray	May show cavities, but CT is better

🫁 CT Scan Signs: What Do Radiologists Look For?

Feature	Bronchiectasis	COPD	CPA / Aspergillosis
Airway shape	Widened, thickened (signet-ring sign)	Narrowed or normal	May have overlapping bronchiectasis
Lung tissue	Scarring, mucus plugging	Blackened areas (emphysema)	Cavities, fungal balls, fibrosis
Mucus	Often present	Sometimes present	Mucus or fungus in airways
Other signs	Tree-in-bud, cystic changes	Air trapping, flattened diaphragm	Thickened cavity walls, pleural changes

💨 What Are Air Trapping and Hyperinflation?

These are signs that air is getting stuck in the lungs — common in asthma, COPD, ABPA, and sometimes CPA.

🔹 Air trapping

Air gets into the lungs but can’t get out fully. You may feel like you can’t finish exhaling.

Seen on CT scan as dark areas during breathing out.
Lung function tests show high residual volume (RV).
Common in asthma, ABPA, bronchiectasis, and COPD.

🔹 Hyperinflation

The lungs are permanently overfilled with air, even when you’re not trying to breathe in.

Seen on CT/X-ray as large lungs, flattened diaphragm, and horizontal ribs.
Lung function shows high total lung capacity (TLC).
Common in emphysema, severe asthma, and ABPA.

Why it matters: Both conditions make breathing harder and less efficient, especially when active. Treatment like inhalers, antifungals, airway clearance, or biologics may help.

💊 Treatment Approaches

Treatment	Bronchiectasis	COPD	Aspergillosis
Airway clearance physiotherapy	✅ Essential	Sometimes	✅ Often vital
Antibiotics	✅ Regularly used	During flares	✅ For Aspergillus bronchitis/CPA
Inhalers (bronchodilators)	Sometimes helpful	✅ Core treatment	✅ In ABPA if asthma is present
Steroids	In flares or ABPA	✅ Often	✅ In ABPA
Antifungals (e.g. itraconazole, voriconazole)	❌ Not routine	❌	✅ Main treatment for CPA/ABPA
Pulmonary rehab	✅	✅	✅ May help fatigue/breathlessness
Oxygen	Rare	✅ In advanced disease	✅ In some advanced cases

🧠 Why It’s Complicated

Many patients are misdiagnosed at first:

Aspergillosis can develop on top of COPD or bronchiectasis
A long delay in diagnosis is common
Some people have all three conditions, or overlapping features (e.g. COPD + ABPA)

That’s why blood tests and CT scans are so important — symptoms alone aren’t enough.

✅ Summary Table

Feature	Bronchiectasis	COPD	Aspergillosis
Cause	Infection, immune issues	Smoking, pollutants	Fungal allergy or infection
Airway problem	Widened, mucus-filled	Narrowed, damaged sacs	Cavities, fungus growth or allergy
Diagnostic test	CT scan	Spirometry	CT + Aspergillus IgG/IgE
Key treatment	Clearance + antibiotics	Inhalers, steroids	Antifungals ± steroids

💬 What Should I Ask My Doctor?

Could my symptoms be due to more than one condition?
Have I had a CT scan and Aspergillus blood tests?
Should I be seen by a specialist centre (e.g. for ABPA or CPA)?
Am I using the right inhalers or physiotherapy?
Could I benefit from a sputum test or antifungal treatment?

by GAtherton

🩺 Lung Function Tests Explained: What They Tell Us About Asthma, COPD, Bronchiectasis, and Aspergillosis

If you’re living with a lung condition like asthma, COPD, bronchiectasis, or aspergillosis, you may be asked to have a lung function test. These tests help your medical team understand how well your lungs are working — and how best to treat you.

🌬️ What Are Lung Function Tests?

Lung function tests (also called pulmonary function tests) measure:

How fast and deeply you can breathe
How well your lungs move oxygen into your blood
How much air gets trapped in your lungs

🔬 Main Tests and What They Measure

Test	What It Measures	Why It Matters
Spirometry	Speed and volume of air breathed out	Shows obstruction or reversibility (e.g. in asthma)
Lung volumes	Total size of the lungs and air left after exhaling	Detects air trapping and hyperinflation
Gas transfer (DLCO)	How well gases pass from lungs to blood	Can show scarring, emphysema, or CPA
Bronchodilator test	Measures response to inhaler	Helps diagnose asthma or ABPA

🧠 What Do These Tests Tell Us?

Here’s how different conditions show up in lung function testing:

🟢 Asthma

Airways are narrowed, but often improve with inhalers.
Shows obstruction that improves significantly after a bronchodilator (reversible).
Lung volumes usually normal; DLCO often normal or high.

🔵 COPD

Shows irreversible obstruction — lungs are stiff and narrowed.
Often shows air trapping and hyperinflation.
DLCO is reduced, especially in emphysema.

🟠 Bronchiectasis

May show mild-to-moderate obstruction or mixed patterns.
Sometimes reversible, depending on overlapping asthma or infection.
Lung volumes and DLCO often normal unless CPA or emphysema is also present.

🟣 Aspergillosis

ABPA: Like asthma — obstruction, often with reversibility, air trapping, high IgE and eosinophils.
CPA: May cause a restrictive pattern (lower lung volumes) or reduced DLCO if fibrosis or cavities are present.
Aspergillus bronchitis: May look like bronchiectasis with some obstruction.

💨 What Is Air Trapping?

Air trapping happens when you breathe in, but can’t get all the air back out. Some air stays stuck in the lungs.

Sign	What It Means
High residual volume (RV)	Too much air remains after breathing out
Expiratory CT scan shows dark areas	Parts of the lungs aren’t emptying properly

Common in:

Asthma
ABPA
Bronchiectasis
COPD

🎈 What Is Hyperinflation?

Hyperinflation means your lungs are constantly overfilled with air — not just trapped temporarily, but stretched long-term.

Sign	What It Means
High total lung capacity (TLC)	Lungs are too large due to long-term air trapping
Flattened diaphragm	Lungs are pressing downward on breathing muscles

Common in:

Severe asthma
Emphysema (COPD)
ABPA (when uncontrolled)

📊 Summary Table

Condition	Common Lung Test Features
Asthma	Obstruction, reversible, normal DLCO
ABPA	Obstruction, reversible, air trapping, high IgE
COPD	Fixed obstruction, hyperinflation, low DLCO
Bronchiectasis	Variable obstruction, sometimes reversible
CPA	Restriction or mixed pattern, reduced DLCO
Aspergillus bronchitis	Similar to bronchiectasis, sputum positive for fungus

💬 Why These Tests Matter

They help distinguish what’s causing your symptoms.
They track whether treatment is working (inhalers, steroids, antifungals).
They identify complications like scarring, cavities, or fungal infection.
They help guide eligibility for biologic drugs or oxygen therapy.

📣 Ask Your Doctor:

Have I had a bronchodilator response test?
Do I have air trapping or hyperinflation?
Should we test for Aspergillus (IgG, IgE, sputum)?
Would a CT scan add helpful detail?

by GAtherton

🟣 Aspergillus Bronchitis: A Patient Guide

If you've been diagnosed with bronchiectasis, COPD, or other chronic lung problems, and keep getting infections or mucus that tests positive for Aspergillus, you might be told you have Aspergillus bronchitis. But what does that mean? And how is it different from ABPA (Allergic Bronchopulmonary Aspergillosis)?

This guide explains what Aspergillus bronchitis is, how it’s diagnosed, how common it is, and how it differs from ABPA.

🌬️ What Is Aspergillus Bronchitis?

Aspergillus bronchitis is a chronic fungal infection of the airways caused by Aspergillus fumigatus. It happens in people with damaged or scarred airways, such as:

Bronchiectasis
COPD
Cystic fibrosis
Occasionally asthma (if structural damage exists)

It’s a low-grade infection, not an allergy and not an invasive disease. The fungus lives in the mucus lining the airways, causing persistent inflammation, infection, and symptoms.

🔍 What Are the Symptoms?

Common symptoms	What to know
Persistent cough	Often brings up sticky or brown mucus
Worsening breathlessness	Not always explained by asthma or infection alone
Fatigue or low energy	Common in chronic fungal infections
Frequent infections	May keep returning despite antibiotics
Wheeze	Sometimes, especially in asthma or ABPA overlap
Weight loss or low-grade fever	Possible in long-standing infection

📊 How Common Is It?

Aspergillus bronchitis is underdiagnosed but increasingly recognised — especially in patients referred to specialist centres.

Estimated frequency in different conditions:

Underlying condition	Estimated rate of Aspergillus bronchitis
Bronchiectasis	~5–15%, higher in referral centres
COPD	~1–5%, especially with steroid use
Cystic fibrosis	5–10% (non-allergic cases)
Asthma (alone)	Rare unless bronchiectasis is also present

It may be mistaken for a flare-up or chronic bacterial infection. Many people are told it’s “just colonisation” — but if symptoms persist and Aspergillus keeps growing in sputum, Aspergillus bronchitis should be considered.

🧪 How Is It Diagnosed?

There’s no single test. Diagnosis is based on clinical features plus evidence of fungal growth and a non-allergic immune pattern.

Test	What it shows
Sputum culture / PCR	Repeated detection of Aspergillus
Aspergillus IgG (blood)	Often raised, shows chronic exposure
Aspergillus IgE & eosinophils	Usually normal — helps exclude ABPA
CT scan	Shows bronchiectasis, mucus plugging, but no cavitation
Response to antifungals	Clinical improvement supports diagnosis

🔄 How Is It Different from ABPA?

ABPA is an allergic reaction to Aspergillus that mainly affects people with asthma or cystic fibrosis.
Aspergillus bronchitis, on the other hand, is a fungal infection in damaged airways, not an allergy.

Feature	Aspergillus Bronchitis	ABPA
Type of disease	Chronic fungal infection	Allergic lung disease
Immune markers	High IgG, normal IgE	High IgE and eosinophils
Sputum	Repeated growth of Aspergillus	May or may not grow
CT findings	Bronchiectasis, mucus	Central bronchiectasis, mucus plugs
Treatment	Antifungals only	Steroids ± antifungals
Typical patient	Bronchiectasis, COPD	Asthma (often severe), sometimes CF

Some patients can have both conditions at once, especially those with asthma and bronchiectasis — so testing is important.

💊 Treatment Options

Treatment	Purpose
Oral antifungals (itraconazole, voriconazole)	Main treatment — often for several months
Inhaled antifungals (e.g. nebulised amphotericin)	Alternative if oral drugs not tolerated
Airway clearance physiotherapy	Helps remove mucus and fungal load
Regular sputum testing	To monitor treatment response
Steroids	Not used unless there’s overlapping ABPA or asthma

🧠 Summary

Question	Answer
Is it an infection?	✅ Yes — fungal infection in the airways
Is it an allergy?	❌ No — that’s ABPA
Can it coexist with ABPA?	✅ Yes, in some cases
How is it diagnosed?	Repeated Aspergillus in sputum + high IgG + symptoms
How is it treated?	Antifungal medication (oral or nebulised)
Will it go away?	Often improves with treatment, but monitoring is essential

💬 What to Ask Your Doctor

Could my symptoms be from Aspergillus bronchitis?
Have I had sputum cultures and Aspergillus blood tests (IgG, IgE)?
Would antifungal treatment help me?
Should I be referred to a specialist centre (e.g. for CPA, ABPA, bronchiectasis)?
Am I on the best airway clearance and physiotherapy plan?

by GAtherton